BlackRock Inc. - EVOKE PHARMA INC ownership

Quarter-by-quarter ownership
BlackRock Inc. ownership history of EVOKE PHARMA INC
ValueSharesWeighting
Q1 2022$88,000
-12.0%
177,127
-1.8%
0.00%
Q4 2021$100,000
-56.1%
180,331
+2.7%
0.00%
Q3 2021$228,000
+3.2%
175,559
+9.2%
0.00%
Q2 2021$221,000
-19.9%
160,770
+6.5%
0.00%
Q1 2021$276,000
-23.3%
150,891
+8.2%
0.00%
Q4 2020$360,000
-40.1%
139,474
+8.7%
0.00%
Q3 2020$601,000
-14.9%
128,275
-35.7%
0.00%
Q2 2020$706,000
+908.6%
199,428
+229.5%
0.00%
Q1 2020$70,000
-23.1%
60,532
+8.1%
0.00%
Q4 2019$91,000
+93.6%
55,972
+1.9%
0.00%
Q3 2019$47,000
+46.9%
54,940
+6.4%
0.00%
Q2 2019$32,000
-74.8%
51,636
-39.1%
0.00%
Q1 2019$127,000
-38.6%
84,741
+1.4%
0.00%
Q4 2018$207,000
-12.3%
83,583
+5.5%
0.00%
Q3 2018$236,000
+23.6%
79,191
+3.8%
0.00%
Q2 2018$191,000
+38.4%
76,288
+15.5%
0.00%
Q1 2018$138,000
-6.8%
66,078
+0.8%
0.00%
Q4 2017$148,000
-29.2%
65,529
+5.1%
0.00%
Q3 2017$209,000
+34.0%
62,369
+2.4%
0.00%
Q2 2017$156,000
+20.0%
60,926
+45.7%
0.00%
Q1 2017$130,00041,8030.00%
Other shareholders
EVOKE PHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 87,925$48,0000.01%
Wambolt & Associates, LLC 32,000$18,0000.01%
Virtu Financial LLC 55,336$31,0000.00%
WELLS FARGO & COMPANY/MN 183$00.00%
NORTHERN TRUST CORP 42,121$23,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 3,828$2,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 210,102$117,0000.00%
STATE STREET CORP 72,800$41,0000.00%
MORGAN STANLEY 9,606$5,0000.00%
View complete list of EVOKE PHARMA INC shareholders